Dr. Kyle Wang (PGY 5)

Education

  • Undergraduate: University of North Carolina, Chapel Hill, NC
  • Medical School: University of Pittsburgh School of Medicine, Pittsburgh, PA
  • Internship: University of Pittsburgh School of Medicine, Pittsburgh, PA 


Honors and Awards

Undergraduate:

    • Phi Beta Kappa, University of North Carolina at Chapel Hill, 2008

Medical School:

    • Dean’s Merit Scholarship, University of Pittsburgh School of Medicine, 2009
    • William S. McEllroy Award for Excellence in the Basic Medical Sciences, University of Pittsburgh School of Medicine, 2010
    • Howard Wong Abstract Resident/Student Travel Award, American College of Radiation Oncology, 2011
    • Alpha Omega Alpha Honor Society, 2013 (elected in junior year)


Research Interests

Head and neck cancer, stereotactic body radiotherapy


Publications
(as of 9/12/17)

  • Moon DH, Moon SH, Wang K, Weissler MC, et al. Incidence of, and risk factors for, mandibular osteoradionecrosis in patients with oral cavity and oropharynx cancers. Oral Oncol 2017 Sep;72:98-103. PMID: 28797468.
  • Wang K, Eblan MJ, Deal AM, Lipner M, Zagar TM, et al. Cardiac toxicity after radiotherapy for Stage III non-small-cell lung cancer: Pooled analysis of dose-escalation trials delivering 70 to 90 Gy. J Clin Oncol 2017 May 1;35(13):1387-1394. PMID: 28113017.
  • Wang K, Zanation AM, Chera BS. The role of radiation therapy in the management of sinonasal and ventral skull base malignancies. Otolaryngol Clin North Am 2017 Apr;50(2):419-432. PMID: 28104274.
  • Verma V, Shostrom VK, Zhen W, Zhang M, Braunstein SE, Holland J, Hallemeier CL, Harkenrider MM, Iskhanian A, Jabbour SK, Attia A, Lee P, Wang K, et alInfluence of fractionation scheme and tumor location on toxicities after stereotactic body radiation therapy for large (≥5 cm) non-small cell lung cancer: A multi-institutional analysis. Int J Radiat Oncol Biol Phys 2017 Mar 15;97(4):778-785. PMID: 28244414.
  • Verma V, Shostrom VK, Kumar SS, Zhen W, Hallemeier CL, Braunstein SE, Holland J, Harkenrider MM, Iskhanian A, Neboori HJ, Jabbour SK, Attia A, Lee P, AliteF, Walker JM, Stahl JM, Wang Ket al.  Multi-institutional experience of stereotactic body radiotherapy for large (≥5 centimeters) non-small cell lung tumors. Cancer 2017 Feb 15;123(4):688-696. PMID: 27741355.
  • Chera B, Wang K, Monroe A, Galloway T, et al. Truth or myth: Definitive chemoradiotherapy doesn’t work for HPV/p16 negative oropharyngeal squamous cell carcinoma?  Oral Oncol 2017 Feb;65:125-126. PMID: 27993466.
  • Wang K, Mullins BT, Falchook AD, Lian J, He K, et al. Evaluation of PET/MRI for tumor volume delineation for head and neck cancer. Front Oncol 2017 Jan 23;7:8. PMID: 28168166.
  • Wang K, Sheets NC, Basak R, Chen RC. Ascertainment of postprostatectomy radiotherapy for prostate cancer in the Surveillance, Epidemiology, and End Results database. Cancer 2016 Oct;122(19):3069-3074. PMID: 27352280.
  • Wang K, Amdur RJ, Mendenhall WM, Green R, et al. Impact of post-chemoradiotherapy superselective/selective neck dissection on patient reported quality of life. Oral Oncol 2016 Jul;58:21-26. PMID: 27311398.
  • Shtessel L, Lowden MR, Simon M, Wang K, et al. C. elegans POT-1 and POT-2 repress telomere maintenance pathways. G3 (Bethesda). 2013 Feb;3(2):305-313. PMID: 23390606.
  • Wang KHeron DEClump DAFlickinger JCet alTarget delineation in stereotactic body radiation therapy for recurrent head and neck cancer: a retrospective analysis of the impact of margins and automated PET-CT segmentation. Radiother Oncol 2013 Jan;106(1):90-95. PMID: 23333021.
  • Wang K, Heron DE, Flickinger JC, Rwigema JC, et al. A retrospective, deformable registration analysis of the impact of PET-CT planning on patterns of failure in stereotactic body radiation therapy for recurrent head and neck cancer. Head Neck Oncol 2012 Apr 19;4:12. PMID: 22515371.


Meeting Abstracts/Presentations (recent)

  • Lindsay DP, Caster JM, Wang K, Myung JH, et al. Nanotechnology-based quantification of circulating tumor cells in oligometastatic patients undergoing definitive radiation therapy. American Society for Radiation Oncology Annual Meeting, San Diego, CA, September 24-27, 2017. (Oral presentation.)
  • Wang K, Wong T, Amdur RJ, Mendenhall WM, et al. Pitfalls of PET surveillance in patients with HPV-associated oropharynx cancer treated on a multi-institutional de-intensification trial.  American Society for Radiation Oncology Annual Meeting, San Diego, CA, September 24-27, 2017. (Oral presentation.)
  • Wang K, Pearlstein KA, Mahbooba Z, Sutton S, et al. Xerostomia is an unrecognized complication of whole brain radiotherapy and may be related to parotid dose: A prospective observational trial.  American Society for Radiation Oncology Annual Meeting, San Diego, CA, September 24-27, 2017. (Oral presentation.)
  • Lindsay DP, Caster JM, Wang K, Myung JH, Chen RC, Chera BS, Gupta GP, Jones E, Tepper JE, Varia MA, Zagar T, Hong S, Wang A. Prospective characterization of circulating tumor cells using a nanotechnology-based capture system in oligometastatic patients undergoing definitive radiation therapy.  American Society of Clinical Oncology Annual Meeting, Chicago, IL, June 2-6, 2017. (Poster presentation.)
  • Eblan MJ, Myung JH, Caster JM, Wang K, Green R, et al. Use of nanotechnology-based system for the prospective characterization of circulating tumor cells in oligometastatic cancer patients undergoing radiation therapy. American Society for Radiation Oncology Annual Meeting, Boston, MA, September 25-28, 2016. (Oral presentation.)
  • Caster JM, Eblan MJ, Myung JH, Wang K, et al. Use of a nanotechnology-based system for the prospective characterization of circulating tumor cells in head and neck cancer patients. American Society of Clinical Oncology Annual Meeting, Chicago, IL, June 3-7, 2016. (Poster presentation.)
  • Wang K. Cardiac toxicity after radiation for Stage III non-small cell lung cancer: Pooled analysis of several prospective dose-escalation trials delivering 70-90 Gy. Presented at The Third Annual George F. Shelton Resident Research Symposium, Chapel Hill, NC, May 18, 2016. (Oral presentation.) 
  • Wang K, Mullins B, Falchook A, Lian J, et al.  Comparison of tumor volume delineation on magnetic resonance/positron emission tomography versus standard computed tomography: Is there added value? Multidisciplinary Head and Neck Cancer Symposium, Scottsdale, AZ, February 18-20, 2016. (Poster presentation.)
  • Wang K, Amdur RJ, Mendenhall WM, Green R, et al.  Impact of post-chemoradiation therapy selective neck dissection on patient-reported quality of life. Multidisciplinary Head and Neck Cancer Symposium, Scottsdale, AZ, February 18-20, 2016. (Poster presentation.)